We are developing a topical skin treatment for the serious and rare skin disease Netherton syndrome. A clinical phase I/II trial has started - this will demonstrate safety and efficacy of the treatment in patients with Netherton syndrome.
| Website | http://www.sixerapharma.com |
| Revenue | $1 million |
| Employees | 2 (1 on RocketReach) |
| Founded | 2013 |
| Address | Skeppsbron 16, Stockholm, Stockholm County 111 30, SE |
| Phone | +46 70 631 00 31 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Research, Skin Disease Research, Rare Disease Research, Drug Development, Dermatology, Clinical Stage, Biopharmaceutical, Advanced Therapies, Medical Research |
| Competitors | Amgen, AbbVie, Novartis, Roche, Bristol Myers Squibb, Sanofi, Merck & Co., Inc., Johnson & Johnson, Pfizer, Gilead Sciences +49 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Sixera Pharma employee's phone or email?
Sixera Pharma Questions
The Sixera Pharma annual revenue was $1 million in 2026.
1 people are employed at Sixera Pharma.
Sixera Pharma is based in Stockholm, Stockholm County.
The NAICS codes for Sixera Pharma are [3254, 32, 325].
The SIC codes for Sixera Pharma are [80, 283, 28].
Related Companies
